CDO1 and non-small cell lung carcinoma: Here, the analysis of TCGA data from NSCLC patient samples revealed that CDO1 (cysteine dioxygenase 1), an enzyme that converts cysteine (CYS) to cysteine sulfinic acid (CSA), was epigenetically silenced by promoter methylation and this change predicted a poor prognosis.